HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19632444.
- Also identified by DOI 10.1016/j.athoracsur.2008.12.090.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diverse anticoagulation protocols are used in patients after implantation of ventricular assist devices. No consensus exists, especially in patients with heparin-induced thrombocytopenia type II. In a patient with heparin-induced thrombocytopenia type II, we implanted a left ventricular assist device (HeartMate XVE; Thoratec, Pleasanton, CA). Thirteen months later the device had to be replaced due to mechanical failure with a HeartMate II left ventricular assist device. We report on our successful protocol of perioperative anticoagulation management using heparin and iloprost during surgery and argatroban thereafter.
Medical subject headings
- Heart-Assist Devices
- Prosthesis Implantation